Search hospitals > New York > Middletown

Garnet Health Medical Center

Claim this profile
Middletown, New York 10940
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Kidney Cancer
Conducts research for Non-Small Cell Lung Cancer
91 reported clinical trials
1 medical researcher
Photo of Garnet Health Medical Center in MiddletownPhoto of Garnet Health Medical Center in MiddletownPhoto of Garnet Health Medical Center in Middletown

Summary

Garnet Health Medical Center is a medical facility located in Middletown, New York. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Kidney Cancer, Non-Small Cell Lung Cancer and other specialties. Garnet Health Medical Center is involved with conducting 91 clinical trials across 150 conditions. There are 1 research doctors associated with this hospital, such as Jeffrey M. Stewart.

Area of expertise

1Breast Cancer
Global Leader
Garnet Health Medical Center has run 17 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
Stage III
2Lung Cancer
Global Leader
Garnet Health Medical Center has run 14 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Garnet Health Medical Center

Prostate Cancer
Laryngeal Cancer
Non-Small Cell Lung Cancer
Oropharyngeal Carcinoma
Prostate Adenocarcinoma
Throat Cancer
Lip and Oral Cavity Cancer
Oral Cancers
Breast Cancer
Colon Cancer
Image of trial facility.

Apalutamide + Hormone and Radiation Therapies

for Prostate Cancer

This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Image of trial facility.

Carboplatin Before Surgery

for Prostate Cancer

This phase II trial tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mutation. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping, or slowing the growth of tumor cells. Giving carboplatin before surgery may shrink tumors in patients with high-risk prostate cancer with BRCA1 and BRCA2 gene mutations.
Recruiting1 award Phase 210 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Garnet Health Medical Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security